Synthetic peptide analogs of ArgPro-Pro-Gly-Phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4

Details for Australian Patent Application No. 2004235760 (hide)

Owner The Regents of the University of Michigan Thromgen, Inc.

Inventors Hasan, Ahmed A. K.; Schmaier, Alvin H.

Agent Davies Collison Cave

Pub. Number AU-A-2004235760

PCT Pub. Number WO2004/098628

Priority 10/426,968 01.05.03 US

Filing date 3 May 2004

Wipo publication date 18 November 2004

International Classifications

C07K 014/705 Peptides having more than 20 amino acids

G01N 033/68 Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

G01N 033/58 Investigating or analysing materials by specific methods not covered by groups - involving labelled substances

C07K 007/06 Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 007/18 Peptides having 5 to 20 amino acids in a fully defined sequence

C12N 005/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

A61K 038/08 Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

Event Publications

8 December 2005 PCT application entered the National Phase

  PCT publication WO2004/098628 Priority application(s): WO2004/098628

26 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004235761-Ginkgo biloba extract as a treatment for therapeuticinduced neurotoxicity

2004235755-Nucleic acids and corresponding proteins entitled 109P1D4 useful in treatment and detection of cancer